Press releases

Biocartis Announces Successful Amendment of its Existing Convertible Bonds

Invitation to the Extraordinary Shareholders’ Meeting

Biocartis Announces Launch of Amendment Process and Exchange Offer for its Existing Convertible Bonds

Disclosure of outstanding voting securities

BIOCARTIS ANNOUNCES H1 2022 RESULTS

Biocartis Announces Entry into Comprehensive Recapitalization Arrangements to Strengthen Cash Position and Support Growth

Biocartis Announces 2022 Half-Year Results on 1 September 2022

Results of the Annual Shareholders’ Meeting held on 13 May 2022

Biocartis Reports Results of First Quarter of 2022: On Track to Deliver on Full-Year Guidance, Gross Margin on Products of 35%

Invitation to the Annual Shareholders’ Meeting